Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

NCT04730427 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Covid19

Interventions

DRUG: GX-I7
DRUG: GX-I7 vehicle

Sponsor

Genexine, Inc.